Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Super-Potent Drug: Out of specification potency results were obtained.
- Products
-
- Levothyroxine Sodium Tablets
- Company
- Mylan Institutional, Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 1,068 cartons
- About this recall
- Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.